SCHEMBL17829115

SCHEMBL17829115

c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6ccc7c8ccccc8n(-c8ccccc8)c7c6)cc54)nc4c3ccc3ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.41
KDM4E B2RXH2 3/20 0.41
ATM Q13315 1/20 0.41
HDAC4 P56524 1/20 0.34
MAPT P10636 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
HSP90AA1 P07900 1/20 0.32
AVPR1A P37288 1/20 0.32
LMNA P02545 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
IL1R1 P14778 1/20 0.32
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829100 0.99 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17828931 0.98 L3MBTL1 (0.43) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17829091 0.97 KDM4E (0.38) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17829221 0.96 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17829084 0.96 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL18026403 0.95 ALDH1A1 (0.36) L3MBTL1KDM4EATMMAPTALDH1A1
SCHEMBL18058356 0.94 L3MBTL1 (0.37) L3MBTL1KDM4EATMMAPTALDH1A1
SCHEMBL19271601 0.94 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17828919 0.94 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL17828941 0.93 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 L3MBTL1 271/4885KDM4E 2236/4885ATM 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.